Clinical characteristics of multiple sclerosis in Taiwan: a cross-sectional study. (Q48450454)

11 February 2018

title

Clinical characteristics of multiple sclerosis in Taiwan: a cross-sectional study. (English)

1 reference

11 February 2018

0 references

K H Chang

1

1 reference

11 February 2018

R K Lyu

2

1 reference

11 February 2018

C M Chen

3

1 reference

11 February 2018

W C Hsu

4

1 reference

11 February 2018

Y R Wu

5

1 reference

11 February 2018

S T Chen

6

1 reference

11 February 2018

L S Ro

7

1 reference

11 February 2018

publication date

1 August 2006

1 reference

11 February 2018

Multiple Sclerosis Journal

published in

1 reference

11 February 2018

volume

12

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

501-506

1 reference

11 February 2018

Multiple sclerosis in the Japanese population

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

Multiple sclerosis amongst Chinese in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

Multiple sclerosis amongst Chinese in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

The prevalence of multiple sclerosis in the world: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

Clinical data and the identification of special forms of multiple sclerosis in 1271 cases studied with a standardized documentation system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

Evoked potentials for evaluation of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

Immunosuppressive treatment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1297OA

10.1191/1352458506MS1297OA

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018